• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Current, new, and emerging therapies for managing hyperglycaemia in type 2 diabetes.

作者信息

Munro Neil, Feher Michael D

出版信息

Br J Gen Pract. 2008 Aug;58(553):531-3. doi: 10.3399/bjgp08X319684.

DOI:10.3399/bjgp08X319684
PMID:18682016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2486380/
Abstract
摘要

相似文献

1
Current, new, and emerging therapies for managing hyperglycaemia in type 2 diabetes.2型糖尿病高血糖管理的当前、新型及新兴疗法
Br J Gen Pract. 2008 Aug;58(553):531-3. doi: 10.3399/bjgp08X319684.
2
Type 2 diabetes - controlling hyperglycaemia with early insulin use.2型糖尿病——早期使用胰岛素控制高血糖
Aust Fam Physician. 2010 Aug;39(8):565-9.
3
Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1.模拟胰淀素和胰高血糖素样肽1作用的新兴疗法。
Diabetes Care. 2006 Feb;29(2):435-49. doi: 10.2337/diacare.29.02.06.dc05-1267.
4
Managing hyperglycaemia.控制高血糖
Br J Gen Pract. 2008 Oct;58(555):729; authore reply 729-30. doi: 10.3399/bjgp08X342408.
5
Extent of glycemic control in type 2 diabetes mellitus: close, but no cigar.2型糖尿病患者的血糖控制程度：接近目标，但未达标。
Nutr Metab Cardiovasc Dis. 2009 Nov;19(9):593-5. doi: 10.1016/j.numecd.2009.08.009.
6
Intensified glucose lowering in type 2 diabetes: don't throw the baby out with the bathwater.2型糖尿病强化降糖治疗：勿因噎废食。
Diabetologia. 2011 Mar;54(3):705-6; author reply 707-8. doi: 10.1007/s00125-010-1991-6. Epub 2010 Dec 3.
7
Managing hyperglycaemia in patients with type 2 diabetes and known cardiovascular disease.2型糖尿病合并已知心血管疾病患者的高血糖管理。
J R Soc Med. 2012 Jan;105(1):2-4. doi: 10.1258/jrsm.2011.110162.
8
Diabetes mellitus in the next decade: novel pipeline medications to treat hyperglycemia.未来十年的糖尿病治疗：新型药物管线治疗高血糖。
Clin Ther. 2013 May;35(5):714-23. doi: 10.1016/j.clinthera.2013.04.007.
9
Effect of different pharmacological formulations of gliclazide on postprandial hyperglycaemia.
Diabet Med. 1998 Aug;15(8):706. doi: 10.1002/(SICI)1096-9136(199808)15:8<706::AID-DIA654>3.0.CO;2-6.
10
Do not forget that type 2 diabetes does not only expose to cardiovascular complications.不要忘记，2型糖尿病不仅会引发心血管并发症。
Diabetes Metab. 2014 Jun;40(3):167-8. doi: 10.1016/j.diabet.2014.03.005. Epub 2014 Apr 18.

引用本文的文献

1
Optimum control of blood glucose for prevention and treatment of ischemic and hemorrhagic stroke.血糖的最佳控制用于预防和治疗缺血性和出血性中风。
Curr Treat Options Cardiovasc Med. 2009 Jun;11(3):201-11. doi: 10.1007/s11936-009-0021-9.
2
Managing hyperglycaemia.控制高血糖
Br J Gen Pract. 2008 Oct;58(555):729; authore reply 729-30. doi: 10.3399/bjgp08X342408.

本文引用的文献

1
Sirtuins: novel targets for metabolic disease in drug development.沉默调节蛋白：药物研发中代谢疾病的新靶点。
Biochem Biophys Res Commun. 2008 Aug 29;373(3):341-4. doi: 10.1016/j.bbrc.2008.06.048. Epub 2008 Jun 23.
2
Effects of intensive glucose lowering in type 2 diabetes.强化降糖对2型糖尿病的影响。
N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.
3
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.2型糖尿病患者强化血糖控制与血管转归
N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.
4
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus.用于2型糖尿病的二肽基肽酶-4（DPP-4）抑制剂。
Cochrane Database Syst Rev. 2008 Apr 16;2008(2):CD006739. doi: 10.1002/14651858.CD006739.pub2.
5
Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus.利拉鲁肽是一种每日注射一次的人胰高血糖素样肽-1（GLP-1）类似物，可改善2型糖尿病患者高血糖期间的胰腺β细胞功能和精氨酸刺激的胰岛素分泌。
Diabet Med. 2008 Feb;25(2):152-6. doi: 10.1111/j.1464-5491.2007.02333.x. Epub 2008 Jan 14.
6
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.罗格列酮对心肌梗死风险及心血管原因所致死亡的影响。
N Engl J Med. 2007 Jun 14;356(24):2457-71. doi: 10.1056/NEJMoa072761. Epub 2007 May 21.
7
The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study.吡格列酮对2445例2型糖尿病合并既往心肌梗死患者再发心肌梗死的影响：PROactive（PROactive 05）研究结果
J Am Coll Cardiol. 2007 May 1;49(17):1772-80. doi: 10.1016/j.jacc.2006.12.048. Epub 2007 Apr 16.
8
Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes.艾塞那肽长效释放制剂每周一次给药对2型糖尿病患者血糖控制和体重的影响。
Diabetes Care. 2007 Jun;30(6):1487-93. doi: 10.2337/dc06-2375. Epub 2007 Mar 12.
9
SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents.通过高通量筛选获得的SIRT1调节化合物作为抗炎和胰岛素增敏剂
J Biomol Screen. 2006 Dec;11(8):959-67. doi: 10.1177/1087057106294710. Epub 2006 Nov 12.
10
Therapeutic intervention in the GLP-1 pathway in Type 2 diabetes.2型糖尿病中GLP-1途径的治疗干预。
Diabet Med. 2006 Mar;23 Suppl 1:14-9. doi: 10.1111/j.1464-5491.2006.01833e.x.